Innospec (IOSP) Stock Could Be 25% Undervalued Despite Steady Cash Flow
5 days ago
A Simply Wall St analysis suggests Innospec stock is 25% undervalued based on discounted cash flow projections. The assessment highlights the specialty chemicals firm's capacity upgrades and R&D spending as key drivers for future cash generation.
Simply Wall Street
2026-04-25
Innospec declares $0.87 dividendShow all 92 updates